These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38581978)

  • 1. Size exclusion chromatography of biopharmaceutical products: From current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles.
    D'Atri V; Imiołek M; Quinn C; Finny A; Lauber M; Fekete S; Guillarme D
    J Chromatogr A; 2024 May; 1722():464862. PubMed ID: 38581978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteins.
    Goyon A; Fekete S; Beck A; Veuthey JL; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():368-378. PubMed ID: 29936373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of being metal-free: The critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry.
    Murisier A; Fekete S; Guillarme D; D'Atri V
    Anal Chim Acta; 2021 Oct; 1183():338987. PubMed ID: 34627511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation.
    Goyon A; D'Atri V; Colas O; Fekete S; Beck A; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():35-43. PubMed ID: 28946123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct coupling of size exclusion chromatography and mass spectrometry for the characterization of complex monoclonal antibody products.
    Murisier A; Andrie M; Fekete S; Lauber M; D'Atri V; Iwan K; Guillarme D
    J Sep Sci; 2022 Jun; 45(12):1997-2007. PubMed ID: 35278285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product.
    He Y; Friese OV; Schlittler MR; Wang Q; Yang X; Bass LA; Jones MT
    J Chromatogr A; 2012 Nov; 1262():122-9. PubMed ID: 22999205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products.
    Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling non-denaturing chromatography to mass spectrometry for the characterization of monoclonal antibodies and related products.
    Farsang E; Guillarme D; Veuthey JL; Beck A; Lauber M; Schmudlach A; Fekete S
    J Pharm Biomed Anal; 2020 Jun; 185():113207. PubMed ID: 32143115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocols for the analytical characterization of therapeutic monoclonal antibodies. I - Non-denaturing chromatographic techniques.
    Goyon A; D'Atri V; Bobaly B; Wagner-Rousset E; Beck A; Fekete S; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1058():73-84. PubMed ID: 28549280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of size exclusion chromatography columns packed with sub-3μm particles for the analysis of biopharmaceutical proteins.
    Goyon A; Beck A; Colas O; Sandra K; Guillarme D; Fekete S
    J Chromatogr A; 2017 May; 1498():80-89. PubMed ID: 27914608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical performance of multiple size-exclusion chromatography columns connected in series.
    Gritti F
    J Chromatogr A; 2020 Dec; 1634():461673. PubMed ID: 33189963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry.
    Liu H; Gaza-Bulseco G; Chumsae C
    J Am Soc Mass Spectrom; 2009 Dec; 20(12):2258-64. PubMed ID: 19786356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies.
    Xu CF; Zang L; Weiskopf A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():230-8. PubMed ID: 24835510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size-exclusion chromatography using reverse-phase columns for protein separation.
    Huang TY; Chi LM; Chien KY
    J Chromatogr A; 2018 Oct; 1571():201-212. PubMed ID: 30146374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in native high-performance liquid chromatography and intact mass spectrometry for the characterization of biopharmaceutical products.
    Tassi M; De Vos J; Chatterjee S; Sobott F; Bones J; Eeltink S
    J Sep Sci; 2018 Jan; 41(1):125-144. PubMed ID: 28990739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microflow size exclusion chromatography to preserve micromolar affinity complexes and achieve subunit separations for native state mass spectrometry.
    Hecht ES; Obiorah EC; Liu X; Morrison L; Shion H; Lauber M
    J Chromatogr A; 2022 Dec; 1685():463638. PubMed ID: 36379198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theory and practice of size exclusion chromatography for the analysis of protein aggregates.
    Fekete S; Beck A; Veuthey JL; Guillarme D
    J Pharm Biomed Anal; 2014 Dec; 101():161-73. PubMed ID: 24816223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments.
    Cernosek T; Jain N; Dalphin M; Behrens S; Wunderli P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Mar; 1235():124037. PubMed ID: 38335765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidimensional LC-MS with
    Verscheure L; Detremmerie S; Stals H; De Vos J; Sandra P; Lynen F; Borgions F; Sandra K
    J Chromatogr A; 2024 Jul; 1726():464947. PubMed ID: 38724406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput multiplex analysis of mAb aggregates and charge variants by automated two-dimensional size exclusion-cation exchange chromatography coupled to mass spectrometry.
    Lambiase G; Inman SE; Muroni M; Lindo V; Dickman MJ; James DC
    J Chromatogr A; 2022 May; 1670():462944. PubMed ID: 35344792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.